Calendrier des promotions Clover Biopharmaceuticals, Ltd.
À propos de l'entreprise Clover Biopharmaceuticals, Ltd.
Clover Biopharmaceuticals, Ltd., биотехнологическая компания, занимается исследованиями, разработкой и коммерциализацией новых вакцин и биологических терапевтических кандидатов. plus de détailsParamètres de base
Grade
Sous-estimation
| Nom | Signification | Grade |
| P/S | 16.92 | 1 |
| P/BV | -0.9063 | 0 |
| P/E | 0 | 0 |
Efficacité
| Nom | Signification | Grade |
| ROA | -4.08 | 0 |
| ROE | 19.78 | 6 |
| ROIC | 0 | 0 |
Dividendes
| Nom | Signification | Grade |
| Rendement en dividendes | 0 | 0 |
| DSI | 0 | 0 |
| Croissance moyenne du dividende | 0 | 0 |
Devoir
| Nom | Signification | Grade |
| Debt/EBITDA | -0.1483 | 10 |
| Debt/Ratio | 0.1686 | 10 |
| Debt/Equity | -3.87 | 10 |
Impulsion de croissance
| Nom | Signification | Grade |
| Rentabilité Revenue, % | 29638.64 | 10 |
| Rentabilité Ebitda, % | 6554.43 | 10 |
| Rentabilité EPS, % | 128.36 | 10 |
paper.price.prices
| Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
| common.calendar.number_days.1 | 0.208 HK$ | 0 HK$ | 0 HK$ | 0 % | 0 % | 0 % |
| common.calendar.number_days.7d | 0.202 HK$ | 0 HK$ | 0 HK$ | 2.97 % | 0 % | 0 % |
| common.calendar.number_days.30d | 0.216 HK$ | 0 HK$ | 0 HK$ | -3.7 % | 0 % | 0 % |
| common.calendar.number_days.90d | 0.222 HK$ | 0.187 HK$ | 0.325 HK$ | -6.31 % | 0 % | 0 % |
| common.calendar.number_days.180d | 0.315 HK$ | 0.187 HK$ | 0.37 HK$ | -33.97 % | 0 % | 0 % |
| common.calendar.number_days.1y | 0.42 HK$ | 0.187 HK$ | 0.51 HK$ | -50.48 % | 0 % | 0 % |
| common.calendar.number_days.3y | 5.47 HK$ | 0.187 HK$ | 5.7 HK$ | -96.2 % | 0 % | 0 % |
| common.calendar.number_days.5y | 0 HK$ | 0.187 HK$ | 14.18 HK$ | 0 % | 0 % | 0 % |
| common.calendar.number_days.10y | 0 HK$ | 0.187 HK$ | 14.18 HK$ | 0 % | 0 % | 0 % |
| common.calendar.number_days.ytd | 0.305 HK$ | 0.187 HK$ | 0.37 HK$ | -31.8 % | 0 % | 0 % |
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
| Superviseur | Titre d'emploi | Paiement | Année de naissance |
| Dr. Peng Liang Ph.D. | Founder, Chief Scientific Officer & Chairman of the Board | 4.97M | 1961 (64 année) |
| Mr. Joshua G. Liang | CEO & Executive Director | 8.83M | 1993 (32 année) |
| Dr. Yang Li Ph.D. | Chief Technology Officer | N/A | |
| Ms. Htay Htay Han MBBS | Chief Medical Officer of Vaccine | N/A | 1969 (56 années) |
| Dr. Berry Michael Ph.D. | Chief Technical Operation Officer | N/A | 1966 (59 années) |
| Ms. Abigail Bracha Ph.D. | Senior Vice President of Corporate Strategy & Business Development | N/A | |
| Ms. Tracy Wang | Senior Vice President of Head of Regulatory Affairs, China | N/A | |
| Dr. Nicholas Jackson M.Sc., Ph.D. | President of Global Research & Development | N/A | 1971 (54 année) |
| Mr. LiongHo Chua | President of Greater China | 1964 (61 année) | |
| Dr. Igor Smolenov M.D., Ph.D. | Executive Vice President of Global Clinical Development Vaccines |
Informations sur l'entreprise
Adresse: China, Shanghai, No. 758 West Nanjing Road - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.cloverbiopharma.com
Site web: https://www.cloverbiopharma.com
